Mark has always been ahead of the curve. And that's what we're gonna talk about today. Everyone, please welcome Mark Cuban.

Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Shares of Vincerx Pharma saw volatile trading on Wednesday, swinging between gains and losses after the company unveiled ...

But they are increasingly facing a crafty adversary: bacteria that mutate and adapt and outwit the very drugs designed to ...

Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

UnitedHealth Group (NYSE:UNH) introduced its 2025 outlook ahead of its Investor Conference on Wednesday, which had to be ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.nXY4Viq9.js ...

Recent health news highlights include Novavax's $200 million sale of its Czech unit, UnitedHealth's higher medical cost ...

This year has seen sharp stock moves as companies report financial results and update investors on early and mid-stage drug studies ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.